Nexien Biopharma, Inc. (NXEN) SEC Filing 10-Q Quarterly report for the period ending Thursday, December 31, 2020

Nexien Biopharma, Inc.

CIK: 1625288 Ticker: NXEN
Document and Entity Information - shares
6 Months Ended
Dec. 31, 2020
Feb. 11, 2021
Cover [Abstract]  
Entity Registrant NameNEXIEN BIOPHARMA, INC. 
Entity Central Index Key0001625288 
Document Type10-Q 
Document Period End DateDec. 31, 2020 
Amendment Flagfalse 
Current Fiscal Year End Date--06-30 
Entity Reporting Status CurrentYes 
Entity Interactive Data CurrentYes 
Entity Filer CategoryNon-accelerated Filer 
Entity Small Business Flagtrue 
Entity Emerging Growth Companytrue 
Entity Ex Transition Periodfalse 
Entity Shell Companyfalse 
Entity Common Stock, Shares Outstanding 55,931,196
Document Fiscal Period FocusQ2 
Document Fiscal Year Focus2021 

View differences made from one quarter to another to evaluate Nexien Biopharma, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Nexien Biopharma, Inc..


Assess how Nexien Biopharma, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Nexien Biopharma, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


Ticker: NXEN
CIK: 1625288
Form Type: 10-Q Quarterly Report
Accession Number: 0001493152-21-003367
Submitted to the SEC: Thu Feb 11 2021 3:56:56 PM EST
Accepted by the SEC: Thu Feb 11 2021
Period: Thursday, December 31, 2020
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: